Histamine H4 receptor antagonists: The new antihistamines?

Current Opinion in Investigational Drugs

Volumn 5, Issue 11, 2004, Pages 1174-1183

  Fung Leung, Wai Pai ^a   Thurmond, Robin L ^a   Ling, Ping ^a   Karlsson, Lars ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Allergy; Chemotaxis; Eosinophils; Histamine; Histamine H4 receptor; Mast cells

Indexed keywords

ANTIHISTAMINIC AGENT; CIMETIDINE; CLOBENPROPIT; DIPHENHYDRAMINE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; IMETIT; INTERLEUKIN 6; JNJ 5207852; JNJ 7777120; OUP 16; PHOSPHOLIPASE C; PIPERAZINE DERIVATIVE; RANITIDINE; STEROID; THIOPERAMIDE; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; LIGAND;

ALLERGY; ASTHMA; ATOPY; BINDING AFFINITY; BRONCHOSPASM; CELLULAR DISTRIBUTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; EOSINOPHIL; HEMATOPOIETIC CELL; HISTAMINE METABOLISM; HUMAN; MAST CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY;

ANIMALS; EOSINOPHILS; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; LIGANDS; MAST CELLS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE;

EID: 9144238856     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Barger G, Dale HH: The presence in ergot and physiological activity B-iminazoylethylamine. J Physiol (1910) 40:38-40.
2. 1-Antihistamines: More relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol (2003) 112(4 Suppl):S42-S52.
3. 1-receptors: Localization and role in airway physiology and in immune functions. J Allergy Clin Immunol (2003) 112(4 Suppl):S60-S68.
4. 1 receptors in late-phase reaction of allergic conjunctivitis. Eur J Pharmacol (2002) 440(1):79-82.
5. 1 receptor-deficient mice. Int Immunopharmacol (2002) 2(6):745-750.
6. 1 receptor signaling. J Exp Med (1999) 189(4):673-682.
7. 2 receptors. Nature (2001) 413 (6854):420-425.
8. Barocelli E, Ballabeni V: Histamine in the control of gastric acid secretion: A topic review. Pharmacol Res (2003) 47(4):299-304.
9. 2 receptor-deficient mice. J Clin Invest (2000) 105(12):1741-1749.
10. Tanaka S, Hamada K, Yamada N, Sugita Y, Tonai S, Hunyady B, Palkovits M, Falus A, Watanabe T, Okabe S, Ohtsu H et al: Gastric acid secretion in L-histidine decarboxylase-deficient mice. Gastroenterology (2002) 122(1):145-155.
11. Furutani K, Aihara T, Nakamura E, Tanaka S, Ichikawa A, Ohtsu H, Okabe S: Crucial role of histamine for regulation of gastric acid secretion ascertained by histidine decarboxylase-knockout mice. J Pharmacol Exp Ther (2003) 307(1):331-338.
12. Kubota Y, Ito C, Sakurai E, Watanabe T, Ohtsu H: Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J Neurochem (2002) 83 4):837-845.
13. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS: Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: Evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci (2002) 22(17):7695-7711.
14. Dere E, De Souza-Silva MA, Topic B, Spieler RE, Haas HL, Huston JP: Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo-and ventro-striatal dopamine turnover. Learn Memory (2003) 10(6):510-519.
15. 1 antihistamines. Ann Allergy (1991) 67(6):625-633.
16. 1 receptors. Proc Natl Acad Sci USA (1996) 93(23):13316-13320.
17. 3 receptors. Mol Pharmacol (2002) 62(2):389-397.
18. Morimoto T, Yamamoto Y, Yamatodani A: Brain histamine and feeding behavior. Behav Brain Res (2001) 124(2 ):145-150.
19. Fulop AK, Foldes A, Buzas E, Hegyi K, Miklos IH, Romics L, Kleiber M, Nagy A, Falus A, Kovacs KJ: Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene. Endocrinology (2003) 144(10):4306-4314.
20. 3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest (2002) 110 12):1791-1799.
21. Morimoto T, Yamamoto Y, Mobarakeh JI, Yanai K, Watanabe T, Yamatodani A: Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav (1999) 67(5):679-683.
22. 4-receptor agonist: (-)-2-Cyano-1-methyl-3-[(2R,5R)-5-[1H-imidazol4(5) -yl]tetrahydrofuran-2-y]methylguanidine. J Med Chem (2003) 46(14):3162-3165.
23. 4 receptor antagonists. J Med Chem (2003) 46(19):3957-3960.
24. 4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther (2004 309 1):404-413.
25. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther (2003) 305(3):1212-1221.
26. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E et al: Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett (2001) 502(1-2):53-56.
27. Travis ER, Wang YM, Michael DJ, Caron MG, Wightman RM: Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice. Proc Natl Acad Sci USA (2000) 97(1):162-167.
28. Dvorak AM: Histamine content and secretion in basophils and mast cells. Prog Histochem Cytochem (1998) 33 3-4):169-320.
29. Masini E, Di Bello MG, Raspanti S, Fomusi Ndisang J, Baronti R, Cappugi P, Mannaioni PF: The role of histamine in platelet aggregation by physiological and immunological stimuli. Inflamm Res (1998) 47(5):211-220.
30. Ohuchi Y, Ohtsu H, Sakurai E, Yanai K, Ichikawa A, Radvany Z, Darvas Z, Falus A, Watanabe T: Induction of histidine decarboxylase in type 2 T helper lymphocytes treated with anti-CD3 antibody. Inflamm Res (1998) 47(Suppl 1):S48-S49.
31. Belke K, Baron J, Schmutzler W, Zwadlo-Klarwasser G: Histidine decarboxylase expression in human monocytes, macrophages and macrophage subsets. Int Arch Allergy Immunol (1999) 118 2-4):353-354.
32. Kubo Y, Nakano K: Regulation of histamine synthesis in mouse CD4+ and CD8+ T lymphocytes. Inflamm Res (1999) 48 3):149-153.
33. Haak-Frendscho M, Darvas Z, Hegyesi H, Karpati S, Hoffman RL, Laszlo V, Bencsath M, Szalai C, Furesz J, Timar J, Bata-Csorgo Z et al Histidine decarboxylase expression in human melanoma. J Invest Dermatol (2000) 115(3):345-352.
34. Karlstedt K, Nissinen M, Michelsen KA, Panula P: Multiple sites of L-histidine decarboxylase expression in mouse suggest novel developmental functions for histamine. Dev Dyn (2001) 221 1):81-91.
35. Laszlo V, Rothe G, Hegyesi H, Szeberenyi JB, Orso E, Schmitz G, Falus A: Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation. Inflamm Res (2001) 50(8):428-434.
36. Szeberenyi JB, Pallinger E, Zsinko M, Pos Z, Rothe G, Orso E, Szeberenyi S, Schmitz G, Falus A, Laszlo V: Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett (2001) 76 3):175-182.
37. 1 receptors. Inflamm, Res (2003) 52(Suppl 1):S53-S54.
38. 3-receptors. Neuroscience (1987) 23(1):149-157.
39. Prinz C, Zanner R, Gerhard M, Mahr S, Neumayer N, Hohne-Zeil B, Gratzl M: The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol (1999) 277(5 Pt 1):C845-C855.
40. Barbry P, Champe M, Chassande O, Munemitsu S, Champigny G, Lingueglia E, Maes P, Frelin C, Tartar A, Ullrich A: Human kidney amiloride-binding protein: cDNA structure and functional expression. Proc Natl Acad Sci USA (1990) 87(19):7347-7351.
41. Yamauchi K, Sekizawa K, Suzuki H, Nakazawa H, Ohkawara Y, Katayose D, Ohtsu H, Tamura G, Shibahara S, Takemura M: Structure and function of human histamine N-methyltransferase: Critical enzyme in histamine metabolism in airway. Am J Physiol (1994) 267(3 Pt 1):L342-L349.
42. Barnes WG, Hough LB: Membrane-bound histamine N-methyltransferase in mouse brain: Possible role in the synaptic inactivation of neuronal histamine. J Neurochem (2002) 82 5):1262-1271.
43. Tanaka S, Deai K, Inagaki M, Ichikawa A: Uptake of histamine by mouse peritoneal macrophages and a macrophage cell line, RAW264.7. Am J Physiol Cell Physiol (2003) 285 3):C592-C598.
44. Ohtsu H, Kuramasu A, Tanaka S, Terui T, Hirasawa N, Hara M, Makabe-Kobayashi Y, Yamada N, Yanai K, Sakurai E, Okada M et al: Plasma extravasation induced by dietary supplemented histamine in histamine-free mice. Eur J Immunol (2002) 32(6 ):1698-1708.
45. Grundemann D, Liebich G, Kiefer N, Koster S, Schomig E: Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol (1999) 56(1):1-10.
46. Ash AS, Schild HO: Receptors mediating some actions of histamine. 1966. Br J Pharmacol (1997) 120(4 Suppl):302-314, discussion 300-301.
47. 2-receptors. Nature (1972) 236(5347):385-390.
48. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem (2000) 275(47):36781-36786.
49. 4) expressed in bone marrow. Mol Pharmacol (2001 59 3):420-426.
50. Morse KL, Behan J, Laz TM, West RE Jr, Greenfeder SA, Anthes JC, Umland S, Wan Y, Hipkin RW, Gonsiorek W, Shin N et al: Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther (2001) 296(3):1058-1066.
51. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF: Discovery of a novel member of the histamine receptor family. Mol Pharmacol (2001) 59(3):427-433.
52. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li X, Herrity NC et al: Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol (2001) 59(3):434-441.
53. 3 receptor. Mol Pharmacol (1999) 55 6):1101-1107.
54. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL: International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev (1997) 49(3):253-278.
55. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K: Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun (2000) 279(2):615-620.
56. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol (2004) 142(1):161-171.
57. Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES: Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care Med (1994) 149 6):1506-1511.
58. 3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn J Pharmacol (1994) 66(2 ):173-180.
59. 3 receptors. Am J Respir Cell Mol Biol (1996) 14(6 ):620-626.
60. 3 receptor antagonists. Bioorg Med Chem Lett (2002) 12 22):3309-3312.
61. 3 receptor antagonists A-304121 and A-317920: In vitro pharmacological effects. J Pharmacol Exp Ther (2003) 305(3):887-896.
62. 3 receptor antagonists: 4-(aminoalkoxy benzylamines. J Med Chem (2003) 46(18):3938-3944.
63. 4 ligands. Mini Rev Med Chem (2004): 4:993-1000.
64. 4 receptor. Mol Pharmacol (2002) 62(1):38-47.
65. Leurs R, Smit MJ, Timmerman H: Molecular pharmacological aspects of histamine receptors. Pharmacol Ther (1995) 66 3):413-463.
66. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol (2000) 1(1):11-21.
67. 4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther (2001) 299(1):121-130.
68. 4 receptor. Br J Pharmacol (2003) 140(6):1117-1127.
69. 2 histamine receptor desensitization and induces cell maturation. Mol Pharmacol (2002) 62(6):1506-1514.
70. 2 receptor mRNA and internalization of the receptor protein (R1). Cell Mol Life Sci (2003) 60(9):1968-1981.
71. Clark RA, Gallin JI, Kaplan AP: The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 142 6):1462-1476.
72. Clark RA, Sandler JA, Gallin JI, Kaplan AP: Histamine modulation of eosinophil migration. J Immunol (1977) 118 1):137-145.
73. 4 receptor on human eosinophils-role in eosinophil chemotaxis. J Recept Signal Transduct Res (2002) 22(1-4):431-448.
74. Wiener Z, Buzas E, Kovacs P, Csaba G, Szabo D, Kittel A, Pallinger E, Watanabe T, Ohtsu H, Ichikawa A, Nagy A, Falus A: Highly reduced peritoneal mast cell number and decreased c-kit expression in histidine decarboxylase knock out mice. Inflamm Res (2001) 50 Suppl 2):S55-S56.
75. Wiener Z, Andrasfalvy M, Pallinger E, Kovacs P, Szalai C, Erdei A, Toth S, Nagy A, Falus A: Bone marrow-derived mast cell differentiation is strongly reduced in histidine decarboxylase knockout, histamine-free mice. Int Immunol (2002) 14(4):381-387.
76. 3 autoreceptors modulate histamine synthesis through cAMP pathway. Mol Pharmacol (2002) 61(1):239-245.
77. Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB: Eosinophil inflammation in asthma. Am J Respir Crit Care Med (1994) 150(5 Pt 2):S33-S38.
78. Macfarlane AJ, Kon OM, Smith SJ, Zeibecoglou K, Khan LN, Barata LT, McEuen AR, Buckley MG, Walls AF, Meng Q, Humbert M et al Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol (2000) 105(1 Pt 1):99-107.
79. 4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther (2003) 307(3):1072-1078.
80. Weller PF: The immunobiology of eosinophils. N Engl J Med (1991) 324(16):1110-1118.
81. Giembycz MA, Lindsay MA: Pharmacology of the eosinophil. Pharmacol Rev (1999) 51(2)213-340.
82. Gleich GJ, Adolphson CR, Leiferman KM: The biology of the eosinophilic leukocyte. Annu Rev Med (1993) 44:85-101.
83. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB: Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 92(4):537-548.
84. Pincus SH, DiNapoli AM, Schooley WR: Superoxide production by eosinophils: Activation by histamine. J Invest Dermatol (1982) 79(1):53-57.
85. 2 receptors mediate the inhibitory effect of histamine on human eosinophil degranulation. Br J Pharmacol (2000) 131(3):482-488.
86. Wadee AA, Anderson R, Sher R: In vitro effects of histamine on eosinophil migration. Int Arch Allergy Appl Immunol (1980) 63(3):322-329.
87. Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, Collins PD, Williams TJ: Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol (1999) 162(5):2946-2955.
88. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell (1994) 76(2):301-314.
89. 2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells. J Pharmacol Exp Ther (2002) 303(1):300-307.
90. 1 receptor. Biochem Biophys Res Commun (1993) 197(3 ):1601-1608.
91. 2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol (1994) 112 3):847-854.
92. 3-receptors. Nature (1987) 327 6118):117-123.
93. 3-receptor. Eur J Med Chem (1992 27 511-517.
94. 2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. J Pharmacol Exp Ther (1983) 224(1 :171-179.